Multiple Sclerosis Clinical Trial

Multiple sclerosis (MS) is a chronic disease of the central nervous system (CNS). Onset typically occurs between the ages of 20 and 40 years. Evidence suggests that MS is an autoimmune disease that causes inflammation and damage in the central nervous system It is the most common disabling neurological disease of young adults.

African Americans are at higher risk of developing more severe episodes with quicker progression of the disease. African Americans have a greater risk of eventual disability as a result of the disease than Caucasian Americans. While Hispanic and Latino Americans have less risk of developing MS compared to Caucasian Americans, they may have a younger average age of onset with greater disease severity and faster progression.

Meridian is conducting a clinical research study for use of a medication in African Americans and Hispanic and Latino Americans aged 18 to 65 with MS.

Eligible participants…

• Must be age 18 to 65
• Must self-identify as African American, or Hispanic, or Latino American
• Must have a diagnosis of relapsing multiple sclerosis at enrollment
• May receive compensation for time and travel
• Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.

You can also talk to a Meridian enrollment specialist about this study by calling (757) 226-0655.